Curriculum Vitae (Abridged)


A vibrant, engaging research scientist, with a background in pharmacology and molecular toxicology; actively seeking new research collaborations and innovation partners focusing primarily on drug-induced liver injury. A skilful committed professional, with a proven track record,  willingness to learn and ability to manage and communicate effectively with people of all ages and abilities.

Education and Employment History 

July 2023 - Present: Education Lead. Deputy Head of Department, Senior Lecturer in Pharmacology, Deputy Director MSc Pharmacology and Toxicology.
Department of Pharmacology and Therapeutics, University of Liverpool, ISMIB.

My Vision: To create a fully engaged and supported workforce to deliver high quality teaching, research and impact in Pharmacology and Therapeutics to meet the needs of the UK government Life Sciences Vision and ABPI skills gap.

I have strategic oversight of all Pharmacology containing programmes spanning students from across the HLS / SCS faculties alongside P&T clinical, academic, and professional service colleagues. I have recently been appointed to EE for Bangor University BSc Pharmacology, to the XJTLU joint centre management board, ISMIB education committee and NC3Rs studentship assessment panel.  My initial tasks were to recruit, integrate and develop P&T teaching fellows.   I have lead on the development and delivery of our new curriculum in line with various policies/procedures e.g Liverpool curriculum framework, BPS Inclusive Curriculum, Biomedical Science Benchmark standards, UK Professional Standards Framework, SEDA values  and to facilitate the articulation of our XJTLU students cohort into Level 5.  I am also to helping to establish a MPharmacy programme collaborating with various stakeholders. 

I currently teach on BSc Pharmacology, BSc Biochemistry, MSc Pharmacology and Toxicology, MSc Drug Discovery and AI programmes within the School of Biosciences. 

Since 2020 I have secured £594’111 external funding from NC3Rs, AMMF and NWCR to establish and develop precision cut tissue slices (PCTS) in Liverpool.  This has been facilitated by fruitful collaborations with colleagues at Liverpool University Hospital Trust, University of Liverpool, Liverpool John Moores University  enabling me to secure an Honorary Senior Lecturer role within Pharmacology and Therapeutics at The University of Liverpool.  The versatility of this technique means that it can easily be adapted for use on healthy and disease tissue from a variety of organs and species providing ample avenues for future exploration and collaboration.  In collaboration with colleagues at LJMU, I have utilised mathematical modelling to optimise our incubation parameters.  I believe this translational model can bridge the gap from in vitro / in vivo models and man.  Implementation of PCTS has enabled me to explore hepatobiliary cancers, primarily focusing on cholangiocarcinoma to explore therapeutic drug response, cellular bioenergetics, validation of novel drug targets and aid in biomarker discovery. 

Jan 2010 - June 2023: Senior Lecturer in Biomolecular Sciences.
School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University.

I was previously employed as a senior lecturer within the School of Pharmacy and Biomolecular sciences at Liverpool John Moores University (LJMU), teaching primarily on the biomedical science, biochemistry and forensic related programmes.  This required me to teach a wide variety of topics and skills to a diverse group of students. My integrated approach exploring physiological, pharmacological and toxicological processes allows me to improve our understanding of the chemical and cellular signalling systems involved with human disease process, from the initial contact of the chemical toxin through to pathological outcome. The focus of my research is to further our understanding of the chemical, biochemical and molecular mechanisms of drug-induced liver injury, particularly focusing on cellular defence and hepatoprotective mechanisms. 


Sept 2010 -Sept 2013: PGCert Learning and Teaching in Higher Education (PGCert LTHE). Academic Enhancement, Faculty of Education, Community and Leisure, 
Liverpool John Moores University.

   This HEA and SEDA accredited course was designed to enable HE teachers to develop the practical skills, theoretical understanding and critical perspectives necessary to facilitate student learning. This programme also allowed participants to demonstrate their professional practice through research and scholarly activity. 

  • Research Project: ‘Compensating academic failure: Are we rewarding student disengagement and the deficit model of teaching?’ Poster presented at LJMU Teaching and Learning conference.
  • Modules included: Observation of Practice in the HE Context, Pedagogic Research and Evaluation, Learning, Teaching and Assessing in HE, Design for Learning in the HE Context (60 master level credits).


Jan 2007 - Dec 2009: Post Doctoral Research 2. 

An investigation into the chemical and molecular basis of the prevention of drug-induced liver injury by Nrf2 (Wellcome trust funded).MRC Centre for Drug Safety Science,  Department of Pharmacology, The University of Liverpool. Supervisors: Dr Chris Goldring, Dr Neil Kitteringham and Prof Kevin Park.

The aim of this Wellcome Trust funded project was to define the role of Nrf2 in the adaptive response of the liver to chemical stress. This was induced by a panel of model hepatotoxins for which the toxicophore is formed through metabolic activation during both acute and chronic toxicity. The Nrf2 pathway plays an important role in the defence of the liver against hepatotoxins, as demonstrated by the fact Nrf2 deficient strains are more susceptible to the toxic effects of model toxins such as paracetamol. However, it may also be induced by the hepatotoxins themselves, thereby raising the threshold for toxicity following repeat exposure.


Feb 2005-Dec 2006: Post Doctoral Research 1. 

Development of transcription factor reporter assays as biomarkers for chronic toxicity. 
Department of Pharmacology and Therapeutics, The University of Liverpool and Pfizer PGRD. 
Supervisors: Dr Chris Goldring, Dr Paul Hayter and Prof Kevin Park.

The aim of my research was to improve our understanding on the mechanistic basis of hepatotoxicity by attempting to identify and develop novel, selective, early biomarkers of toxicity. Thus providing important information for the design, safety evaluation, and clinical application of new drugs. My studies focused on the Nrf2-Keap1-ARE signalling pathway and defence gene induction in in vitro systems. The key aims for this post were to develop a fluorescent transcription factor based, hepatotoxicity screen for the cellomics HCS platform to assess the validity of transcription factor activation as a screen for determining oxidative stress in new chemical entities. As part of this research I entered into new research fields, of which I had little technical experience. This project was tackled from two different angles, generation of transcription factor-fluorescent protein constructs for imaging in live cells. Alongside the generation of the generation of a human Nrf2 antibody, raised against both a peptide fragment and the whole recombinant protein for imaging in fixed cells. 
 

PhD Pharmacology and Toxicology.

Department of Pharmacology and Therapeutics, The University of Liverpool. 
Supervisors: Prof. Kevin Park and Dr Dominic Williams.

The aim of these studies were to investigate protective and defensive mechanisms within the liver. In particular to ‘examine the role of adrenergic modulation of chemical-induced hepatotoxicity’. Previous studies had suggested an important role for adrenoceptors in modulating the susceptibility of the liver to hepatotoxicity; however the ability for α adrenergic antagonists to protect against paracetamol toxicity, a clinically relevant widely available toxin when ingested in overdose, had not been investigated. Clinical Chemistries and histopathological analysis, performed in collaboration with the Department of Safety Sciences (Pfizer PGRD Sandwich,) confirmed prazosin mediated hepatoprotection. This protection was not due to alterations in the metabolism of the hepatotoxicant. It appears that α1 antagonist can counteract stress induced vasoconstriction with the hepatic microvasculature, helping to maintain a nutritive blood flow to the liver and aiding hepatocellular regeneration. In conjunction with Drs. Jean Satish and Dominic Williams, we have developed an assay using fluorescently labelled red blood cells and FACS analysis to determine hepatic congestion


BSc (1st Class Hons.) Pharmacology. 

Department of Pharmacology and Therapeutics, The University of Liverpool.

Dissertation: ‘The metabolism of a novel 4-aminoquinoline anti-malarial’. Amodiaquine, a 4-aminoquinoline anti-malarial is associated with adverse side effects including agranulocytosis and hepatic damage. Interchanging the 3’hydroxyl and the 4’ Mannich side chain prevented the formation of the electrophilic metabolite and in vivo bioactivation whilst maintaining anti-malarial efficacy. This project gave a firm grounding in general lab techniques, including LC/MS and radioactive tissue distribution via scintillation counting. This provided me with a foundation for developing my practical, analytical and problem-solving skills.

Research Grants


  • ‘Development of a novel chick embryo model to discover and investigate therapeutics for uveal melanoma metastatic to the liver.’ £270’068, 10/24 – 9/27.  A collaboration between The University of Liverpool, Clatterbridge Cancer Research (UK), Immunocore Ltd, University of Lancaster, Thomas Jeffereson university (USA) and Liverpool University Hospitals Trust.

  • 2023 AMMF Research Grant (Co-I).
    ‘Interrogating tumour-mediated immunosuppression in peri-hilar cholangiocarcinoma’   £25’000, 08/23-08/25. A collaboration between The University of Liverpool and Liverpool University Hospitals Trust.

  • 2022 NC3Rs Ph.D. Studentship (PI)
    ‘Manipulating cholangiocarcinoma immune-phenotype in a patient derived precision-cut tumour model (hPCTS) to improve immune checkpoint inhibition response.’ £119’980 total, 10/23 – 9/27. A collaboration between Liverpool John Moores University (£31,584), The University of Liverpool (£88,400) and Liverpool University Hospitals Trust.

  • 2022 North West Cancer Research Ph.D. Studentship (PI)
    ‘Establishing the immune-profile of cholangiocarcinoma and the utility of human precision cut tumour slices (hPCTS) as a platform to assess immunotherapy response.’ £104’970 total, 10/2022-09/25. A collaboration between Liverpool John Moores University (£29,820), The University of Liverpool (£75,150) and Liverpool University Hospitals Trust.

  • 2021 Kuwait Ministry of Health Ph.D. Studentship (Co-I)
    ‘Determining the role of metabolic phenotype in the progression of cholangiocarcinomas using human hepatic organoids (HOO) and Precision Cut Tissue Slices (hPCTS).’ £34’250 tuition and bench fees per annum, 01/2022 – 01/2026 at The University of Liverpool.

  • 2021 NC3Rs Skills and Knowledge transfer Grant (PI),
    ‘Determine the efficacy and safety of cancer chemotherapeutics for cholangiocarcinoma (CCA) using Human Precision Cut Tissue Slices (hPCTS).’ £74’093 total funding, 09/2021 – 08/2023. A collaboration between Liverpool John Moores University (£47,238), The University of Liverpool (£80,400) and Liverpool University Hospitals Trust.

Technical Skills
A wide variety of ADME, molecular and toxicological techniques including In vivo and in vitro models, mechanisms of toxicity, high content screening (HCS), drug metabolism, proteomics, investigating cellular defence mechanisms.

Membership of Learned Societies

Full member of British Toxicology Society (BTS)
Full member of British Pharmacology Society (BPS)
Full member of Royal Society of Biology (MRSB)

Professional Accreditation:

Fellowship of Higher Education Academy (FHEA, 2013 - present).

Awards

Merseyside Scouts Commendation Award for Marvellous Medicine Badge Day (2025).

Commended for ‘Outstanding Contribution to Public Engagement’, ISMIB PE Working Group, UoLiv staff awards 2025.

 LJMU Faculty of Science Research and Knowledge Exchange Award Winner (2022)


11th European ISSX Conference (2009) Post Doctoral Poster prize winner.
http://www.issx.org/i4a/pages/index.cfm?pageid=3362

9th European ISSX Conference (2006) Pre-doctoral Poster prize runner–up.

Winner of Best Young Researcher’s Poster Prize,
Royal Liverpool and Broadgreen University Hospital NHS Trust, R & D Open Day (2004).

Pfizer’s Drug Discovery 2003 - Drug Metabolism Winner,
PGRD Drug Discovery European Postgraduate Poster Symposium.

University of Liverpool Precint Article Jan 2004, pg 20. http://www.liv.ac.uk/precinct/archives.htm

Papers:

  1. McGreevy O, Gilbert T, Jessel MD, Bosakhar, M., Fenwick, S., Malik, H., Goldring, C. and Randle, L. A Preclinical Model of Human Liver Using Precision Cut Tissue Slice Culture [v1] F1000Research 2025, 14:571. https://doi.org/10.12688/f1000research.162495.1 *corresponding author.

  2. Gilbert, T.M., Randle, L., Quinn, M., McGreevy, O., O’Leary, L., Young, R., Diaz-Neito, R., Jones, R.P., Greenhalf, B., Goldring, C., Fenwick, S. Malik, H. and Palmer, D. Molecular biology of cholangiocarcinoma and its implications for targeted therapy in patient management. EJSO. Article in press https://doi.org/10.1016/j.ejso.2024.108352 *Joint first author

  3.  McGreevy, O., Bosakhar, M. Gilbert, T., Quinn, M., Fenwick, S. Malik, H., Goldring, C., and Randle, L. 2024. The importance of preclinical models in cholangiocarcinoma. EJSO, Article in press 108304. https://doi.org/10.1016/j.ejso.2024.108304

  4. Chidlow, S.J., Randle, L.E*. and Kelly, R.A., 2022. Predicting physiologically-relevant oxygen concentrations in precision-cut liver slices using mathematical modelling. PloS one, 17(11), p.e0275788. (255 views, IF 3.58, SJR 0.852). ISSN 19326203 DOI: 10.1371/journal.pone.0275788 *Contribution: concept(i), organisation(ii), data analysis & interpretation (iii) *Joint corresponding author.
  5. Kelly, R.A., Leedale, J., Harrell, A., Beard, D.A., Randle, L.E., Chadwick, A.E. and Webb, S.D. (2018). Modelling the impact of changes in the extracellular environment on the cytosolic free NAD+/NADH ratio during cell culture. PLoS ONE, 13: e0207803-e0207803. (2369 views, 7 citations, IF 3.58, SJR 0.852). ISSN 19326203. DOI: 10.1371/journal.pone.0207803 *Contribution: organisation(ii), data analysis & interpretation (iii).
  6. Del Casino, A., Valentina, L., Rakesh, B., Randle, L.E., Dascombe, M.J., Fennell, D.B.J., Drew, M.G.B., Angus, B., Fielding, A.J. and Ismail, F.M.D. (2018). Synthesis, Structural Determination, and Pharmacology of Putative Dinitroaniline Antimalarials. Chem Select, 3:7572-7580. (6 citations, IF 2.109, SJR 0.437 Q2). ISSN 23656549 DOI: 10.1002/slct.201801723 *Contribution: concept(i), organisation(ii), data analysis & interpretation (iii.)
  7. Fielding, A.J., Evans, P.G., Alizadeh, S., Bisby, R., Drew, M.G.B., Del Casino, A., Dunn, J.F., Randle, L.E., Dempster, N.M., Nahar, L., Sarker, S.D., Cantú Reinhard, F.G., de Visser, S.P., Dascombe, M.J. and Ismail, F.M.D. (2017). Modulation of Antimalarial Activity at a Putative Bisquinoline Receptor in vivo Using Fluorinated Bisquinolines Chemistry - A European Journal. (9 citations, IF 5.236, SJR 1.687 Q1). ISSN 09476539, DOI: 10.1002/chem.201605099 *Contribution: organisation(ii), data analysis & interpretation (iii).
  8. Eakins,R., Walsh,J., Randle, L.*, Jenkins, R.E., Schuppe-Koistinen, I., Rowe, C., Starkey Lewis, P., Vasieva, O., Prats, N., Brilliant, N., Auli, M., Bayliss, M., Webb, S., Rees, J.A., Kitteringham, N.R., Goldring, C.E. and Park, B.K. (2015) Adaptation to acetaminophen exposure elicits major changes in expression and distribution of the hepatic proteome. Scientific Reports, 5: 16423. ISSN 20452322,  DOI: 10.1038/srep16423*Contribution: concept(i), organisation(ii), data analysis & interpretation (iii) *Joint first author (5498 views, 28 citations, IF 4.379 SJR 1.240).
  9. Stachulski, A.V., Baillie, T.A., Park, B.K., Obach, S.R., Dalvie, D.K., Williams, D.P., Srivastava, A., Regan, S.L., Antoine, D.J., Goldring, C.E., Chia, A.J., Kitteringham, N.R., Randle, L.E., Callan, H., Castrejon, J.L., Farrell, J., Naisbitt, D.J., Lennard, M.S. (2012).  The Generation, Detection, and Effects of Reactive Drug Metabolites.  Med Res Rev. doi: 10.1002/med.21273.  (65 citations, IF 12.994, SJR 2.868 Q1). ISSN 10981128, DOI: 10.1002/med.21273 *Contribution: data analysis & interpretation (iii).
  10. Kitteringham, N.R., Abdullah, A., Walsh, J., Randle, L., Jenkins, R.E., Sison, R., Goldring, C.E., Powell, H., Sanderson, C., Williams, S., Higgins, L., Yamamoto, M., Hayes, J. and Park, B.K. (2010).  Proteomic Analysis Of Nrf2 Deficient Transgenic Mice Reveals Cellular Defence And Lipid Metabolism As Primary Nrf2-Dependent Pathways In The Liver.  Proteomics, 73(8):1612-31. (127 citations inc. 1 patent family, IF 3.537, SJR 1.067) ISSN 18743919, DOI: 10.1016/j.jprot.2010.03.018 *Contribution: organisation (ii), data analysis & interpretation (iii).
  11. Copple, I.M., Goldring, C.E., Jenkins, R.E., Chia, A.J., Randle, L.E., Hayes, J.D., Kitteringham, N.R. and Park, B.K. (2008). The Hepatotoxic Metabolite Of Acetaminophen Directly Activates The Keap1-Nrf2 Cell Defence System.  Hepatology, 48(4):1292-301.  (108 citations inc. 1 patent family, IF 17.42, SJR 5.488 Q1). ISSN 02709139, DOI: 10.1002/hep.22472 *Contribution: data analysis & interpretation (iii).
  12. Randle LE, Goldring CE, Benson CA, Metcalfe PN, Kitteringham NR, Park BK, Williams DP (2008). Investigation Of The Effect Of A Panel Of Model Hepatotoxins On The Nrf2-Keap1 Defence Response Pathway In CD-1 Mice.  243(3):249-60. (49 citations, IF 4.221 SJR 1.067 Q1). ISSN 0300483X. DOI: 10.1016/j.tox.2007.10.011 *Contribution: organisation (ii), data analysis & interpretation (iii).
  13. Randle LE, Sathish JG, Kitteringham NR, Macdonald I, Williams DP, Park BK. (2008) Alpha(1)-Adrenoceptor Antagonists Prevent Paracetamol-Induced Hepatotoxicity In Mice. J. Pharmacol. 153(4):820-30. (IF 8.739 SJR 2.432 Q1, 29 citations). ISSN 14765381, DOI: 10.1038/sj.bjp.0707620 *Contribution: organisation (ii), data analysis & interpretation (iii).
  14. Williams DP, Antoine DJ, Butler PJ, Jones R, Randle L, Payne A, Howard M, Gardner I, Blagg J, Park BK (2007). The Metabolism And Toxicity Of Furosemide In The Wistar Rat And CD-1 Mouse: A Chemical And Biochemical Definition Of The Toxicophore. Pharmacol. Exp. Ther. Sep;322(3):1208-20. (54 citations inc 1 patent family, IF 3.561 SJR 1.3 Q1). ISSN 15210103, DOI: 10.1124/jpet.107.125302 *Contribution: data analysis & interpretation (iii).
  15. Goldring, C.E., Kitteringham, N.R., Jenkins, R., Lovatt, C.A., Randle, L.E., Abdullah, A., Owen, A., Liu, X., Butler, P.J., Williams, D.P., Metcalfe, P., Berens, C., Hillen, W., Foster, B., Simpson, A., McLellan, L., & Park, B.K. (2006). Development Of A Transactivator In Hepatoma Cells That Allows Expression Of Phase I, Phase II, And Chemical Defence Genes. J. Physiol. Cell Physiol. 290 (1), C104-15. (654 downloads,27 citations, IF 4.249, SJR 1.432 Q1) ISSN 15221563, DOI:10.1152/ajpcell.00133.2005 *Contribution: data analysis & interpretation (iii).
  16. Goldring, C.E., Kitteringham, N.R., Elsby, R., Randle, L.E., Clement, Y.N., Williams, D.P., Mcmahon, M., Hayes, J.D., Itoh, K., Yamamoto, M. & Park, B.K. (2004). Activation Of Hepatic Nrf2 In Vivo By Acetaminophen In CD-1 Mice. Hepatology, 39, 1267-76. (172 citations inc 1 patent family, IF 17.42, SJR 5.488 Q1). ISSN 02709139, DOI: 10.1002/hep.20183 *Contribution: data analysis & interpretation (iii).
  17. O'Neill, P.M., Mukhtar, A., Stocks, P.A., Randle, L.E., Hindley, S., Ward, S.A., Storr, R.C., Bickley, J.F., O'Neil, I.A., Maggs, J.L., Hughes, R.H., Winstanley, P.A., Bray, P.G. & Park, B.K. (2003). Isoquine And Related Amodiaquine Analogues: A New Generation Of Improved 4-Aminoquinoline Antimalarials. J Med. Chem, 46, 4933-45. (3038 views133 citations, IF 7.446, SJR 2.010 Q1) ISSN 00222623, DOI: 10.1021/jm030796n *Contribution: data analysis & interpretation (iii).

 

Selected Abstracts presented at Scientific Conferences:

  1. Gilbert, T, Randle, L, Diaz-Neito, R, Jones, R, Fenwick, S, Goldring, C and Malik, H. Developing a patient-derived model of cholangiocarcinoma using Precision Cut Tissue Slices (PCTS). J. Surgery, 109, Supp 9, 2022, znac404.020, Abstract 219, AUGIS Annual Meeting, Aberdeen, 21 –23/9/22.
  2. Ismail, F. M. D., Morris, H., Dempster, N.M., Saleem, I.Y., Randle, L.E., Kasaija, F., Alizadeh-Shekalgourabi, S., Evans, P.G., Dascombe, M.J. Drew, M.G. and Edwards, G (2011). Deducing The Definitive Geometry Of Chloroquine-Haematin Interactions Using Mass Spectrometry And DFT Investigations. BMSS Meeting 2011.
  3. Goldring, C.E., Randle, L.E., Sison, R., Kitteringham, N.R., Denk, D., Jenkins, R.E., Walsh, J., Lane, B., Kipar, A.J., and Park, B.K. (2011). A Biochemical And Proteomic Analysis Of The Effect Of Nrf2 Gene Deletion On Acute Acetaminophen-Induced Hepatotoxicity.  Sci., 120 (Supp 2), 535, Abstract 2500, SOT 2011 Annual Meeting, Washington.
  4. Chia,A., Megherbi, R., Copple,I., Kitteringham, N.R., Randle, L.E., Goldring, C. E., and Park, B.K. (2011). Activation of Nrf2 by intrinsic and extrinsic ligands.  Sci., 120 (Supp 2), 535, Abstract 2498, SOT 2011 Meeting, Washington.
  5. Starkey Lewis, P.J., Goldring, C.E., Platt, V., Obeng, A.M., Randle, L., Rowe, C., Moggs, J., and Park, K. (2011). Profiling The Hepatic Proteome To Explore The Molecular Basis Of The Chronic toxicity Of Acetaminophen. Sci., 120 (Supp 2), 95, Abstract 446, SOT 2011 Annual Meeting, Washington.
  6. Yeang, H. X. Aw., Hamdam, J., Al-Huseini, L., Goodwin, C., Randle, L., Melendez, A., Park, K., Goldring, C., and Sathish, J., (2010). The Transcription Factor Nrf2 Affects Dendritic Cell Maturation And Phagocytic Function.  131 (Supp 1), 107.  BSI Annual Congress 2010.
  7. Randle, L.E., Goldring, C.E., Jenkins, R.E., Denk, D., Antoine, D.J., Sison, R.L., Williams, D.P., Hayes, J.D., Kitteringham, N.R., Park, B.K. (2009). A Biochemical, Toxicological And Proteomic Analysis Investigating The Effect Of Nrf2 Gene Deletion On Paracetamol-Induced Hepatotoxicity In Vivo.  Drug Metab. Rev., 41 (Supp 1), 23-24, Abstract 57, 11th European ISSX Conference 2009, Lisbon.
  8. Randle, L.E., Goldring, C.E., Williams, D.P., & Park, B.K (2006). Mechanism Of Defence During Chemical Induced Hepatotoxicity. Drug Metab. Rev., 38 (Supp 1), 56-58, Abstract 70, 9th European ISSX Conference 2006, Manchester.
  9. Phillips, G.W., Irwin, W.A., Howard-Cofield, E.J., Randle, L.E., Abraham, V.C., Haskins, J.R. and O'Brien, P.J. (2005) Value of Incorporation of an Oxidative Stress Biomarker into High Content Screening (HCS) for Human Toxicity Potential. Society for Biomolecular Sciences Regional Meeting, California.

Research and Knowledge Exchange Online and Media Coverage:

https://www.nc3rs.org.uk/news/nine-new-awards-our-fifth-year-3rs-knowledge-transfer

  • NC3Rs – Skills and Knowledge Transfer Award Overview

https://nc3rs.org.uk/our-portfolio/determining-efficacy-and-safety-cancer-chemotherapeutics-cholangiocarcinoma-cca-using

Gambia TV coverage (PtvGambia) at the presentation of LJMU donated microscope to The University of Gambia, unfortunately I was unable to attend in person due to ongoing COVID 19 restrictions: https://www.youtube.com/watch?v=t_xpmbhEit0

Gunjur project (11/2/21): https://www.facebook.com/GunjurProject/photos/a.186043248129481/3687345337999237/?type=3

The Point (29/4/21) Gambia National Newspaper: https://thepoint.gm/africa/gambia/national-news/utg-receives-25-multi-purpose-lab-microscopes

The University of Gambia (28/4/21): https://www.utg.edu.gm/cftn/?fbclid=IwAR1e9fVY1iSwzpMlDfTxn3Z5jJVr43zCbfc45qxu5205vECY5bjv9SmiMNM

https://www.facebook.com/profile/100064379513413/search/?q=microscopes

  • I provided science demonstrations to the HRH Countess of Wessex at the opening of Girlguiding Cheshire Forest’s new residential accommodation at Pettypool.

Cheshire live: https://www.cheshire-live.co.uk/news/chester-cheshire-news/countess-wessex-opens-award-winning-17066964

Northwich guardian: https://www.northwichguardian.co.uk/news/17963476.sophie-countess-wessex-gives-royal-approval-girlguiding-activity-building-sandiway/#gallery4

Pettypool – Girlguiding Cheshire Forest Facebook page: https://www.facebook.com/media/set/?set=a.2453215114734229&type=3

  • All About Stem case study ‘Non-school groups (Cheshire Girlguiding).

https://drlaurarandle.yolasite.com/stem-ambassador.php

Make a free website with Yola